Here's guidance the FDA offers for patients whose prescriptions for this generic alternative could be affected.

Researchers have uncovered a new way to attack lymphoma by targeting a non-catalytic region of a key regulatory enzyme, rather than its traditional active site. Researchers at VCU Massey Comprehensive ...

Cardiac amyloidosis is a progressive condition that affects the heart and other organs, but new FDA-approved drugs are prolonging the lives of those affected and early identification is now possible.

While proven to help, primary care clinicians have been slow to use the drugs once considered only for patients with diabetes.

(KODE/KSNF) — We’ve heard a lot about the weight loss possibilities for drugs like Ozempic, Mounjaro and Zepbound, but these ...

With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be related to weight loss alone. GLP-1 medications, including semaglutide, are a ...

(CNN) — A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...

A generic version of Vascepa, often prescribed with statins to lower heart attack risk, was recalled because oxidation is ...

Add Yahoo as a preferred source to see more of our stories on Google. Michigan State University scientists have built tiny beating heart organoids that can be driven into atrial fibrillation with ...

Scientists have created a three-dimensional "heart-on-a-chip" (HOC) that could provide a breakthrough in the fight against the world's leading cause of death, cardiovascular disease. One major ...